Ocugen, Inc. (OCGN)
NASDAQ: OCGN · Real-Time Price · USD
1.380
+0.030 (2.22%)
At close: Jan 2, 2026, 4:00 PM EST
1.400
+0.020 (1.43%)
Pre-market: Jan 5, 2026, 8:58 AM EST
Ocugen Market Cap
Ocugen has a market cap or net worth of $431 million as of January 5, 2026. Its market cap has increased by 74.65% in one year.
Market Cap
431.00M
Enterprise Value
431.40M
1-Year Change
74.65%
Ranking
Category
Stock Price
$1.38
Market Cap Chart
Since September 30, 2019, Ocugen's market cap has increased from $32.75M to $431.00M, an increase of 1,216.06%. That is a compound annual growth rate of 50.91%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 2, 2026 | 431.00M | 2.22% |
| Dec 31, 2025 | 421.63M | 79.79% |
| Dec 31, 2024 | 234.51M | 59.00% |
| Dec 29, 2023 | 147.49M | -48.17% |
| Dec 30, 2022 | 284.55M | -68.60% |
| Dec 31, 2021 | 906.30M | 205.66% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 956.28B |
| Johnson & Johnson | 498.15B |
| AbbVie | 405.44B |
| UnitedHealth Group | 306.45B |
| AstraZeneca | 287.81B |
| Novartis AG | 266.00B |
| Merck & Co. | 262.92B |
| Novo Nordisk | 227.63B |